Last update 01 Nov 2024
PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Fusion protein |
Synonyms |
Target |
Mechanism F8 stimulants(Coagulation factor VIII stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Login to view timeline
Related
7
Clinical Trials associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Recombinant Human Coagulation Factor Ⅷ-Fc Fusion Protein (FRSW117) for Injection in Patients With Severe Hemophilia A (Adults and Adolescents)
评价注射用培重组人凝血因子Ⅷ-Fc融合蛋白（FRSW117）在经治重型血友病A患者（成人及青少年）中的有效性、安全性、免疫原性和药代动力学的开放、多中心Ⅲ期临床研究
[Translation] An open, multicenter phase III clinical study to evaluate the efficacy, safety, immunogenicity and pharmacokinetics of recombinant human coagulation factor VIII-Fc fusion protein for injection (FRSW117) in patients with severe hemophilia A (adults and adolescents) who have been treated
在重型血友病A患者（成人和青少年）中评价注射用培重组人凝血因子Ⅷ-Fc融合蛋白（FRSW117）多次给药的药代动力学、安全性和初步疗效的开放、多中心、II期临床研究
[Translation] An open, multicenter, phase II clinical study to evaluate the pharmacokinetics, safety, and preliminary efficacy of multiple doses of recombinant human coagulation factor VIII-Fc fusion protein (FRSW117) for injection in patients with severe hemophilia A (adults and adolescents)
100 Clinical Results associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Translational Medicine associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Patents (Medical) associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Deals associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Phase 3 | CN | 27 Dec 2023 | |
| Hemorrhage | Phase 3 | CN | 27 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 15 | (ptettswjmb) = mtmaidtvck weklgequid (xpyccffvkb ) View more | - | 10 Dec 2023 | |||
(ptettswjmb) = mbcdohtrzj weklgequid (xpyccffvkb ) View more | |||||||
Phase 1 | 13 | (fbauzgkljw) = aeguizbrhs gdfuirjami (fiiailikwz ) | - | 08 Jun 2023 | |||
(fbauzgkljw) = rcfjzivryc gdfuirjami (fiiailikwz ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free